An mRNA SARS-CoV-2 vaccine employing charge-altering releasable transporters with a TLR-9 agonist induces neutralizing antibodies and T cell memory / Ole A. W. Haabeth, Julian J. K. Lohmeyer, Adrienne Sallets, Timothy R. Blake, Idit Sagiv-Barfi, Debra K. Czerwinski, Blaine McCarthy, Abigail E. Powell, Paul A. Wender, Robert M. Waymouth and Ronald Levy

By: Haabeth, Ole A. WContributor(s): Lohmeyer, Julian J. K | Sallets, Adrienne | Blake, Timothy R | Sagiv-Barfi, Idit | Czerwinski, Debra K | McCarthy, Blaine | Powell, Abigail E | Wender, Paul A | Waymouth, Robert M | Levy, RonaldCall Number: IF 120 (69) Material type: ArticleArticleSubject(s): mRNA VACCINES -- IFOnline resources: Link to Open Access In: ACS Central Science Vol. 7, No. 7, 2021, p. 1191-1204
No physical items for this record

YI2021 M10

There are no comments on this title.

to post a comment.